Steve Duffy

Most Recent Articles by Steve Duffy

Galcanezumab Effective in Phase 3 Episodic Cluster Headache Study

Galcanezumab Effective in Phase 3 Episodic Cluster Headache Study

By

The episodic cluster headache trial included a total of 106 patients with an average of 17.5 cluster headache attacks per week at baseline.

FDA Approves Deep Brain Stimulation Therapy for Refractory Epilepsy

FDA Approves Deep Brain Stimulation Therapy for Refractory Epilepsy

By

The approval is specifically for bilateral anterior thalamic nucleus stimulation and is based on results from the SANTE study (Stimulation of the Anterior Nucleus of the Thalamus in Epilepsy).

Results From Phase 3 Trial of Migraine Tx Ubrogepant Released

Results From Phase 3 Trial of Migraine Tx Ubrogepant Released

By

Allergan announced results from the second Phase 3 trial for their novel acute migraine treatment, ubrogepant.

FDA-Approved App Allows Clinicians to Objectively Measure Balance

FDA-Approved App Allows Clinicians to Objectively Measure Balance

By

The application assesses 3 key balance metrics: (1) double stance, (2) right tandem stance, and (3) left tandem stance.

Controversial New Research Changes the Narrative on Hans Asperger

Controversial New Research Changes the Narrative on Hans Asperger

By

Medical records of 48 children examined by Asperger show that he specifically called for 12 of the children to be transferred to the Am Spieglegrund facility, the 'euthanasia' institution founded in 1940.

More Articles by Steve Duffy

Sign Up for Free e-newsletters

CME Focus